Drugs / BioChaperone PDGF-BB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01098357 | Jun 2010 → Feb 2011 | ulcer of lower limbs | Virchow Group | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2012-04-23 | Adocia | Results ADOCIA reports positive phase II clinical results adocia.com ↗ |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2012-04-23 | Adocia | ADOCIA reports positive phase II clinical results adocia.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioChaperone PDGF-BB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01098357 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human Platelet-Derived Growth Factor (rhPDGF-BB)” NCT01098357 ↗ |
| Route | Topical | “BioChaperone PDGF-BB low dose is applied as a spray” NCT01098357 ↗ |